By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 14 percent increase in total revenues for the fourth quarter of 2010 compared to the previous year, as scientific instruments revenues rose 13 percent.

For the three months ended Dec. 31, 2010, Bruker reported revenues of $416.1 million, compared to $366.4 million a year ago and outpacing analyst estimates of $396.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.